Traders should anticipate the pricing announcement within the next 1-2 days, which will set the stage for initial trading. Given the company's pre-revenue biotech status and reliance on clinical development, volatility at launch is likely. Monitor for final offering size and pricing relative to the $225M interest indicated by existing investors.
Price Chart
Executive Summary
Kailera Therapeutics' IPO has become effective, allowing the company to proceed with its initial public offering. The registration statement (S-1) is now live, enabling the company to sell shares to the public and list on Nasdaq under ticker KLRA.
Key Facts
- IPO registration (S-1) has become effective as of April 16, 2026
- Company plans to list on Nasdaq under symbol KLRA
- This is an initial public offering (IPO) by an emerging clinical-stage biotech focused on obesity treatments
- No pricing or final share count disclosed in this filing; expected to follow in a subsequent 424B4 filing
Financial Impact
Undisclosed amount — full offering size and pricing not yet confirmed, though prior S-1 indicated interest from existing investors for $225 million
Risk Factors
- High risk due to early-stage development and lack of revenue
- Potential for significant volatility post-launch given speculative nature of clinical-stage biotechs
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001217 |
| Document: 9999999995-26-001217-index.html | 9999999995-26-001217 |
| Document: 9999999995-26-001217.txt | 9999999995-26-001217 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access